Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

NCT07058051 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07058051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07058051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
July 17, 2025
Completion date
November 13, 2025
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-segmental vitiligo